跳至主要内容
临床试验/NCT04969978
NCT04969978进行中(未招募)不适用

CONNECT: COmpreheNsive TraiNing and Engagement in Cessation Treatment

OHSU Knight Cancer Institute1 个研究点 分布在 1 个国家目标入组 9,133 人开始时间: 2023年6月20日最近更新:
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
9,133
试验地点
1
主要终点
Accepted electronic (e)Referral to Quitline

研究概览

简要总结

This phase IV clinical trial determines the impact of implementing a Quitline electronic (e)Referral system with an enhanced academic detailing implementation strategy on Quitline reach, tobacco cessation assistance and self-reported quit rates among patients in community health centers. It also examines the cost-effectiveness of Quitline eReferrals both with and without enhanced academic detailing. If this implementation strategy is effective, this strategy could be used to increase tobacco cessation treatment through the collaboration between state Quitlines and community health centers that serve large numbers of socioeconomically disadvantaged patients who use tobacco.

详细描述

PRIMARY OBJECTIVES:

I. Implement a Quitline electronic (e)Referral system with enhanced academic detailing (AD) (intervention; n=10 community health centers [CHCs]) and without enhanced AD (comparison; n=10 CHCs) to compare rates of eReferral offers, eReferral acceptance, Quitline enrollment, orders for tobacco cessation medication, and receipt of in-clinic counseling among patients identified as currently using tobacco.

II. Assess the effectiveness of implementing a Quitline eReferral system with enhanced AD (intervention) versus without enhanced AD (comparison) on self-reported tobacco quit rates among all patients identified as current persons using tobacco using electronic health record (EHR) data.

III. Estimate the total annual costs and incremental cost-effectiveness of a Quitline eReferral system, with and without enhanced AD.

OUTLINE: Clinics are randomized to 1 of 2 arms.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • In Oregon
  • On the OCHIN Epic EHR for >= 1 year
  • Willing to be randomized to the intervention or comparison condition
  • Willing to recruit a provider to serve as a clinic champion (to share monthly performance audit and feedback at all-staff meetings, determine desired content of booster sessions with clinic team members, and complete a survey at the completion of the intervention period) and a clinic manager to coordinate training and booster sessions
  • Study Patient Inclusion Criteria:
  • Adult patients (>= 18 years of age)
  • Identified as current tobacco users during >= 1 ambulatory and/or telehealth visit to one of the eligible study clinics over the 24-month study period

排除标准

  • 未提供

研究组 & 干预措施

Arm I (Quitline eReferral)

Active Comparator

Clinics are notified via email that the Quitline eReferral system is available with a link to an online publication that includes an overview of Quitline services, information on Quitline effectiveness, and a detailed eReferral workflow with corresponding EHR screenshots, including how to identify eligible patients, create an eReferral, and access Quitline follow-up data in the EHR. Clinics also gain access to technological assistance, as needed.

干预措施: Informational Intervention (Other)

ARM II (Quitline eReferral plus enhanced AD)

Experimental

Clinics receive standard online materials access to remote technological assistance as in Arm I. Clinics also receive group training of clinic staff prior to activation of the eReferral system and 12 months post-activation, follow-up booster sessions and monthly performance audit and feedback.

干预措施: Enhanced Academic Detailing (Behavioral)

ARM II (Quitline eReferral plus enhanced AD)

Experimental

Clinics receive standard online materials access to remote technological assistance as in Arm I. Clinics also receive group training of clinic staff prior to activation of the eReferral system and 12 months post-activation, follow-up booster sessions and monthly performance audit and feedback.

干预措施: Informational Intervention (Other)

结局指标

主要结局

Accepted electronic (e)Referral to Quitline

时间窗: At any point during the 24-month intervention period

Proportion of patients who accepted a Quitline eReferral in intervention (EAD) versus comparator clinics. Will use a logistic mixed effects model that addresses the following design features of the study: 1) will include random intercepts for providers and clinic to account for clustering of patients within providers within clinics; 2) will perform an intent-to-treat analysis; 3) hypothesis tests will be two-sided.

次要结局

  • Quitline eReferral offered(At any point during the 24-month intervention period)
  • Quitline enrollment(At any point during the 24-month intervention period)
  • Receipt of in-office counseling(At any point during the 24-month intervention period)
  • Tobacco cessation medication ordered(At any point during the 24-month intervention period)
  • Tobacco cessation(At any point during the 24-month intervention period or up to 6 months post-intervention)
  • Annual intervention costs(Years 1-4)
  • Cost-effectiveness(Years 1-4)
  • Incremental cost-effectiveness ratio(Years 1-4)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Steffani Bailey

Principal Investigator

Oregon Health and Science University

研究点 (1)

Loading locations...

相似试验

Electronic Quitline Referral With Enhanced Academic... | 临床试验